Lerodalcibep is currently under regulatory review by both the European Medicines Agency (EMA). In Greater China, Biologics License Application (BLA) submission is expected in 1H 2026, with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback